Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

Clinical trial NCT03709680 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03709680
Sponsor: Pfizer
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ewing Sarcoma Solid Tumors Rhabdoid Tumor Rhabdomyosarcoma Neuroblastoma Medulloblastoma Diffuse Intrinsic Pontine Glioma

Start date: 2019-05-24
Primary completion: 2024-08-26
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.